Your browser doesn't support javascript.
COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia.
Parry, Helen; Bruton, Rachel; Roberts, Thomas; McIlroy, Graham; Damery, Sarah; Sylla, Panagiota; Dowell, Alexander C; Tut, Gokhan; Lancaster, Tara; Bone, David; Willett, Brian; Logan, Nicola; Scott, Sam; Hulme, Sam; Jadir, Azar; Amin, Umayr; Nicol, Sam; Stephens, Christine; Faustini, Sian; Al-Taei, Saly; Richter, Alex; Blakeway, Daniel; Verma, Kriti; Margielewska-Davies, Sandra; Pearce, Hayden; Pratt, Guy; Zuo, Jianmin; Paneesha, Shankara; Moss, Paul.
  • Parry H; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK; University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, UK.
  • Bruton R; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Roberts T; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • McIlroy G; University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, UK; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.
  • Damery S; Institute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK.
  • Sylla P; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Dowell AC; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Tut G; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Lancaster T; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Bone D; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Willett B; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
  • Logan N; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
  • Scott S; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
  • Hulme S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Jadir A; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Amin U; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Nicol S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Stephens C; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Faustini S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Al-Taei S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Richter A; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK; University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, UK.
  • Blakeway D; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Verma K; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Margielewska-Davies S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Pearce H; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Pratt G; University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, UK.
  • Zuo J; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
  • Paneesha S; University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, UK.
  • Moss P; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK; University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, UK. Electronic address: p.moss@bham.ac.uk.
Cancer Cell ; 40(6): 584-586, 2022 06 13.
Article in English | MEDLINE | ID: covidwho-1889265

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Cancer Cell Journal subject: Neoplasms Year: 2022 Document Type: Article Affiliation country: J.ccell.2022.05.001

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Cancer Cell Journal subject: Neoplasms Year: 2022 Document Type: Article Affiliation country: J.ccell.2022.05.001